# Automated Insulin Delivery for INpatients With DysGlycemia (AIDING) Feasibility

> **NCT04714216** · NA · COMPLETED · sponsor: **Emory University** · enrollment: 22 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DEVICE:** The Omnipod 5/Horizon HCL system

## Key facts

- **NCT ID:** NCT04714216
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-29
- **Primary completion:** 2022-08-11
- **Final completion:** 2022-08-11
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2024-04-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04714216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04714216, "Automated Insulin Delivery for INpatients With DysGlycemia (AIDING) Feasibility". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04714216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*